Diagnosis of Acute Appendicitis in ChildrenNCT04527263
Urinary 5-HIAA for Diagnosis of Acute Appendicitis in Children, Does it Help?
A study testing measurement of urinary 5-HIAA in people with Diagnosis of Acute Appendicitis in Children, run by Tanta University at 1 site in Egypt.
Trial summary
it is randomized control study. two groups of children (n=191) were divided into two groups A and B. Group A included children subjected to the classical protocol of diagnosis of acute appendicitis. Read more about this study
- Who is it for?
- Ages 2 to 18 years
- Conditions the study is for
- Diagnosis of Acute Appendicitis in Children
- What is being tested?
- measurement of urinary 5-HIAA
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 191 participants
- Where
- 1 siteEgypt
- Study dates
- 2 Jul 2017to 2 Jul 2020
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 2 to 18 years
- All sexes
- No healthy volunteers
- Child, Adult
Who may be able to join
- all children with suspected acute appendicitis
Who cannot join
- children received drugs that may affect normal values of urinary 5-HIAA as mono mono oxidase inhibitors
Trial locations and contacts
1 site in 1 country.
About this study
Official title: BUILDING UP A DIAGNOSTIC MODEL OF ACUTE APPENDICITIS IN CHILDREN USING URINARY 5-HYDROXY INDOL ACETIC ACID
it is randomized control study. two groups of children (n=191) were divided into two groups A and B. Group A included children subjected to the classical protocol of diagnosis of acute appendicitis. this protocol consisted of pediatric appendicitis score evaluation, pelvi abdominal ultrasound and measurement of serum CRP. Group B, children had the same previous assessment plus measurement of urinary 5-HIAA.
Read the detailed description
1.1- Study design: Patients were randomly categorized into two groups A and B. Randomization was achieved using closed envelop method.
Group A (n= 95) included patients that were evaluated using our institutional protocol. This protocol consists of assessment of children using PAS, ultrasound of abdomen and pelvis and serum levels of C-reactive protein.
Group B (n= 96) included children that were evaluated by our institutional protocol. In addition, all children gave a mid- stream urine sample for spot urinary 5-HIAA detection. Detailed history was taken. This mainly was to exclude cases with history of foods or drugs that may affect level of serotonin in urine such as mono amino oxidase inhibitors.
All related clinical data and laboratory investigations were recorded. 1.2- Quantitation of urinary 5-HIAA level: From each participant, a random urine sample was obtained to assess the urinary 5-HIAA level using a solid phase competitive enzyme-linked immunosorbent assay (ELISA) technique. The commercial kit was purchased and provided by LDN, DN Labor Diagnosika Nord GmbH \& Co. Nordhorn, Germany; Catalog #: BA E-1900. As stated by the manufacturer, the urine samples were methylated to derivatize the 5-HIAA. On the provided microtitre plate, the methylated standards, controls and samples are added. 5-HIAA antiserum was then added and incubated for 1 hour. After equilibration, excess free antigen and antigen-antibody complexes are washed out. The affixed bounded antibodies to the solid phase were detected by an anti-rabbit IgG-peroxidase conjugate using TMB as a substrate. The reaction is measured on a microplate reader (Tecan Spectra II, Switzerland), at 450 nm. Quantification of unknown sample concentration is processed by drawing a standard curve with known standard concentrations. The results of 5-HIAA were divided by urinary creatinine and expressed as mg/g creatinine. The inter-assay and intra-assay coefficient of variation were 10.8% and 8.6% respectively.
1.3- Clinical outcome: Diagnosis of acute appendicitis was confirmed by histopathological examination of resected appendix. According to operative findings and pathological reports, the condition ranged from negative appendix to different types of acute appendicitis (catarrhal, suppurative, perforated or gangrenous).
Children did not full filling the requirements for diagnosis as acute appendicitis were discharged on symptomatic treatment or after referral to pediatric emergency department.
Readmitted cases were recorded. 1.4- Statistical analysis: Statistical analysis was done using IBM SPSS V. 24 (IBM, NY, USA). A descriptive analysis was obtained for patients included in the study. Shapiro-Wilk test was conducted to check for normal distribution of dependent variables, such as urinary 5-HIAA, CRP and histopathological findings. X2 test was used to compare the categorical data. Student T-test was used to compare the normally distributed variable between two groups. Mann-Whitney U test and Kruskal-Wallis test were used for comparing the non-normally distributed variables of two and more than two groups, respectively. Binary logistic regression was performed to determine the independent predictors for acute appendicitis and to combine 5-HIAA and PAS results in both groups. Pearson correlation was used for correlating the urinary 5-HIAA with other acute appendicitis predictors. Receiver operating characteristic (ROC) curve was constructed to assess the diagnostic efficacy of acute appendicitis predictors. The optimal cutoff value for each predictor was assessed via the Youden index. The value of AUC ranged from 0.5 to 1.0. The ability of a diagnostic test to identify patients with appendicitis was considered optimal as AUC value reached closer to 1.0. P-value <0.05 was considered significant
- Being tested
- measurement of urinary 5-HIAA
- Keywords
- appendicitis, children, 5-HIAA, scoring systems
- Medical subject headings
- Appendicitis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
measurement of urinary 5-HIAADiagnostic test
urinary assessment of 5-HIAA
| Study group | Role | What they receive |
|---|---|---|
| group A | Active comparator | subjected to institutional protocol of diagnosis of acute appendicitis Receives: Diagnostic Test: measurement of urinary 5-HIAA |
| group B | Active comparator | subjected to institutional protocol of diagnosis of acute appendicitis plus measurement of urinary 5-HIAA Receives: Diagnostic Test: measurement of urinary 5-HIAA |
What is being measured
The primary outcome is the main question the study is designed to answer.
accurate diagnosis of acute appendicitis in children
number of cases that have been diagnosed as having acute appendicitis
Measured: 1 day
decreasing incidence of negative appendectomy
number of cases that are not appendicitis and not operated
Measured: 1 day
decreasing number of readmitted cases with diagnosis of acute appendicitis
number of cases that had been readmitted with diagnosis of acute appendicitis in both groups
Measured: 3 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 Aug 2020
- Study start2 Jul 2017
- Primary completion1 Jul 2020
- Study completion2 Jul 2020
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Diagnosis of Acute Appendicitis in ChildrenStudies of the same condition, open and under way.
- More trials run by Tanta UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Diagnosis
- Allocation
- Randomised
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 191 participants (actual)
Sponsor and investigators
- Lead sponsor
- Tanta University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Mohammad Gharieb Mohammad Khirallah, Tanta University
- Investigators
- Mohammad G Mohammad, Principal investigator, Tanta University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04527263
- Sponsor's protocol ID
- 33944/7/20
- Status last verified
- Aug 2020
- First submitted
- 22 Aug 2020
- Last updated
- 26 Aug 2020
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 26 Aug 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- BUILDING UP A DIAGNOSTIC MODEL OF ACUTE APPENDICITIS IN CHILDREN USING URINARY 5-HYDROXY INDOL ACETIC ACID
- ClinicalTrials.gov ID
- NCT04527263
- Acronym / sponsor ID
- 33944/7/20
- Keywords
- appendicitis, children, 5-HIAA, scoring systems
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 191 participants (actual)
- Lead sponsor
- Tanta UniversityUniversity, hospital or other
- Study start
- 2 Jul 2017 (actual)
- Primary completion
- 1 Jul 2020 (actual)
- Study completion
- 2 Jul 2020 (actual)
- First posted
- 26 Aug 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
it is randomized control study. two groups of children (n=191) were divided into two groups A and B. Group A included children subjected to the classical protocol of diagnosis of acute appendicitis. this protocol consisted of pediatric appendicitis score evaluation, pelvi abdominal ultrasound and measurement of serum CRP. Group B, children had the same previous assessment plus measurement of urinary 5-HIAA.
Detailed description
1.1- Study design: Patients were randomly categorized into two groups A and B. Randomization was achieved using closed envelop method.
Group A (n= 95) included patients that were evaluated using our institutional protocol. This protocol consists of assessment of children using PAS, ultrasound of abdomen and pelvis and serum levels of C-reactive protein.
Group B (n= 96) included children that were evaluated by our institutional protocol. In addition, all children gave a mid- stream urine sample for spot urinary 5-HIAA detection. Detailed history was taken. This mainly was to exclude cases with history of foods or drugs that may affect level of serotonin in urine such as mono amino oxidase inhibitors.
All related clinical data and laboratory investigations were recorded. 1.2- Quantitation of urinary 5-HIAA level: From each participant, a random urine sample was obtained to assess the urinary 5-HIAA level using a solid phase competitive enzyme-linked immunosorbent assay (ELISA) technique. The commercial kit was purchased and provided by LDN, DN Labor Diagnosika Nord GmbH \& Co. Nordhorn, Germany; Catalog #: BA E-1900. As stated by the manufacturer, the urine samples were methylated to derivatize the 5-HIAA. On the provided microtitre plate, the methylated standards, controls and samples are added. 5-HIAA antiserum was then added and incubated for 1 hour. After equilibration, excess free antigen and antigen-antibody complexes are washed out. The affixed bounded antibodies to the solid phase were detected by an anti-rabbit IgG-peroxidase conjugate using TMB as a substrate. The reaction is measured on a microplate reader (Tecan Spectra II, Switzerland), at 450 nm. Quantification of unknown sample concentration is processed by drawing a standard curve with known standard concentrations. The results of 5-HIAA were divided by urinary creatinine and expressed as mg/g creatinine. The inter-assay and intra-assay coefficient of variation were 10.8% and 8.6% respectively.
1.3- Clinical outcome: Diagnosis of acute appendicitis was confirmed by histopathological examination of resected appendix. According to operative findings and pathological reports, the condition ranged from negative appendix to different types of acute appendicitis (catarrhal, suppurative, perforated or gangrenous).
Children did not full filling the requirements for diagnosis as acute appendicitis were discharged on symptomatic treatment or after referral to pediatric emergency department.
Readmitted cases were recorded. 1.4- Statistical analysis: Statistical analysis was done using IBM SPSS V. 24 (IBM, NY, USA). A descriptive analysis was obtained for patients included in the study. Shapiro-Wilk test was conducted to check for normal distribution of dependent variables, such as urinary 5-HIAA, CRP and histopathological findings. X2 test was used to compare the categorical data. Student T-test was used to compare the normally distributed variable between two groups. Mann-Whitney U test and Kruskal-Wallis test were used for comparing the non-normally distributed variables of two and more than two groups, respectively. Binary logistic regression was performed to determine the independent predictors for acute appendicitis and to combine 5-HIAA and PAS results in both groups. Pearson correlation was used for correlating the urinary 5-HIAA with other acute appendicitis predictors. Receiver operating characteristic (ROC) curve was constructed to assess the diagnostic efficacy of acute appendicitis predictors. The optimal cutoff value for each predictor was assessed via the Youden index. The value of AUC ranged from 0.5 to 1.0. The ability of a diagnostic test to identify patients with appendicitis was considered optimal as AUC value reached closer to 1.0. P-value <0.05 was considered significant
Study design
- Primary purpose
- Diagnosis
- Allocation
- Randomised
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| group A | Active comparator | Diagnostic Test: measurement of urinary 5-HIAAsubjected to institutional protocol of diagnosis of acute appendicitis |
| group B | Active comparator | Diagnostic Test: measurement of urinary 5-HIAAsubjected to institutional protocol of diagnosis of acute appendicitis plus measurement of urinary 5-HIAA |
Who may qualify
- Ages
- 2 to 18 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult
Key inclusion criteria (1 listed)
- all children with suspected acute appendicitis
Key exclusion criteria (1 listed)
- children received drugs that may affect normal values of urinary 5-HIAA as mono mono oxidase inhibitors
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| measurement of urinary 5-HIAAurinary assessment of 5-HIAA | Diagnostic test | group A, group B |
Primary outcome
accurate diagnosis of acute appendicitis in children
Time frame: 1 day
number of cases that have been diagnosed as having acute appendicitis
decreasing incidence of negative appendectomy
Time frame: 1 day
number of cases that are not appendicitis and not operated
decreasing number of readmitted cases with diagnosis of acute appendicitis
Time frame: 3 days
number of cases that had been readmitted with diagnosis of acute appendicitis in both groups
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 26 Aug 2020.
- Individual participant dataSharing planned: Undecided
Related trials for Diagnosis of Acute Appendicitis in Children
RecruitingPhase 4
Magnesium Sulfate in Children Undergoing Laparoscopic Appendectomy
Opioid Consumption, Multimodal Analgesia
Recruiting
The Impact of a Diagnostic Strategy for Acute Appendicitis in Children With Acute Abdominal Pain in Primary Care
Appendicitis Acute, Acute Abdomen in Children
Recruiting
Effects of Cartoons and Mobile Games on Preoperative Anxiety and Fear in Children With Appendicitis: An RCT
Preoperative Anxiety, Children
Not yet recruiting
TACTILE : Validation of a Teleconsultation-Based Predictive Score for the Diagnosis of Acute Appendicitis in Children Using Artificial Intelligence Methods
Acute Appendicitis
RecruitingObservational study
Prostaglandin-E Urinary Metabolite (PGE-M) as a Predictor of Acute Appendicitis in Children
Acute Appendicitis, Acute Appendicitis With Rupture
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Mohammad G Mohammad principal investigator
Tanta University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing measurement of urinary 5-HIAA in people with Diagnosis of Acute Appendicitis in Children, run by Tanta University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 26 Aug 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
accurate diagnosis of acute appendicitis in children (time frame: 1 day). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Aug 2020.